Ian Stansfield

Title: Ian Stansfield: Innovator in Pharmaceutical Compounds

Introduction

Ian Stansfield is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. His work is crucial in the ongoing fight against diseases such as cancer.

Latest Patents

Ian Stansfield holds a patent for "Cyclin-dependent kinase 7 (CDK7) non-covalent inhibitors." This invention relates to pharmaceutical compounds of formula (I) and pharmaceutical compositions that comprise these compounds. The patent outlines processes for the preparation of these compounds and their use as inhibitors of cyclin-dependent kinase 7 (CDK7). This innovation has potential applications in the treatment of various diseases, including cancer.

Career Highlights

Ian Stansfield is currently employed at Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to focus on developing innovative solutions that address critical health challenges. With 1 patent to his name, he continues to contribute to advancements in medical science.

Collaborations

Ian collaborates with talented professionals in his field, including his coworker Sophie Coupa Ép Descamps. Their combined expertise enhances the research and development efforts at Janssen Pharmaceutica NV.

Conclusion

Ian Stansfield is a dedicated inventor whose work in pharmaceutical compounds is making a significant impact in the medical field. His innovative approach to developing CDK7 inhibitors showcases his commitment to advancing healthcare solutions.